CEO of CDMO AustinPx on its exclusive agreement with Thermo Fisher’s Patheon division
Thermo Fisher’s Patheon division has signed an exclusive agreement with AustinPx to install the Texas CDMO’s KinetiSol technology at Patheon’s Bend, Oregon, and Cincinnati sites. AustinPx specializes…
Read the full articleYou might also wanna read
Shilpa Biologicals brings ADC manufacturing capacity to Dharwad, India
The announcement from the Indian CDMO came during the BIO International Convention in San Diego, California.
Pharma JV Spending $500M on Austin Plant Expansion
The planned expansion of a Northwest Austin pharmaceutical manufacturing plant by a multi-national joint venture will nearly double the comp
Thermo Fisher expands Brazil manufacturing with new research plant
Gianluca Pettiti Ana Paula Paiva/Valor U.S. life sciences company Thermo Fisher Scientific, which generates about $45 billion in annual reve
Post-BIO ins and outs: Rentschler and Syngene CEO appointments among big moves
Symeres and Axxam also join the fray, choosing a new CSO to lead their scientific strategy.
AstraZeneca compra a una farmacéutica de China los derechos de un medicamento pulmonar por 1.900 millones
Se trata de un inhibidor dual de PDE3/4 concebido para proporcionar efectos broncodilatadores y antiinflamatorios simultáneos.
Adaptable manufacturing platforms enable in vivo mRNA-LNP delivery, says Lonza
Manufacturing expert Telmo Graça believes a more agile CMC process will reduce costs and bring drugs to market faster.
Comments
Sign in to join the conversation.
No comments yet. Be the first.